Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Leiomyoma 1Breast Neoplasms 1Agnosia 1

Interventions

telapristone acetate 10ulipristal 3asoprisnil 3vilaprisan 2estradiol, norethindrone drug combination 2elagolix 2Norethindrone Acetate 2Mifepristone 2Lidocaine 2Leuprolide 2Estradiol 2ulipristal acetate 1relugolix 1pirfenidone 1epigallocatechin gallate 1Tea 1Sugars 1Simvastatin 1Ropivacaine 1Progesterone 1Morphine 1Methadone 1Injections, Subcutaneous 1Embolization, Therapeutic 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leiomyoma × Injections, Subcutaneous × Clear all
NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡